Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Psoriasis 7Lymphoma, Follicular 7Bronchiolitis Obliterans Syndrome 7Pruritus 5Arthritis, Rheumatoid 3Plaque, Amyloid 1Myasthenia Gravis 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Glioblastoma 1Cholangiocarcinoma 1Arthritis, Psoriatic 1Adenocarcinoma 1

Interventions

guselkumab 3tofacitinib 1sonelokimab 1risankizumab 1cabozantinib 1Vaccines 1Specimen Handling 1Saline Solution 1Platinum Compounds 1Nivolumab 1Ipilimumab 1Infliximab 1Herpes Zoster Vaccine 1Etanercept 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Arthritis, Psoriatic × tofacitinib × Clear all
NCT01519089 2015-08-13

A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis

Pfizer

Phase 3 Completed
95 enrolled 37 charts
Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Psoriasis, Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡